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Abstract
Aim: In an earlier study we have shown that transcervical chorionic villus sampling in excess of 90 mg
increases the risk for hemangiomas of infancy three- to four-fold compared to amniocentesis. In the present
study we investigated whether transabdominal chorionic villus sampling (TA-CVS), in which the samples are
smaller, carries the same risk.
Material and Methods: Retrospectively, data were analyzed from 200 consecutive TA-CVS procedures and 200
consecutive amniocentesis procedures. Forty-two TA-CVS procedures and 27 amniocentesis procedures were
excluded on predeﬁned criteria. Questionnaires were sent to the parents asking if there was any skin mark on
the child: vascular, pigmented or otherwise. All hemangiomas were clinically conﬁrmed.
Results: In the TA-CVS group, 118/158 questionnaires (75%), and in the amniocentesis group 134/173 ques-
tionnaires (77%) were returned. Based on the results of the questionnaire (i.e. mentioning of any skin lesion),
24 children in the TA-CVS group and 42 children in the amniocentesis group qualiﬁed for a physical exami-
nation. In the TA-CVS group 11/118 children (9%) had one or more hemangiomas. In the amniocentesis group
6/134 children (4%) had one or more hemangiomas. There was no statistical difference between the two groups
(P = 0134).
Conclusion: These results suggest that TA-CVS does not cause an increase in the prevalence of hemangioma
compared to amniocentesis. A larger series is, however, necessary to conﬁrm this.
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Introduction
Despite recent advances in the analysis of fetal DNA in
maternal circulation, prenatal invasive procedures are
still needed to exclude chromosomal abnormalities
before birth. Although amniocentesis and chorionic
villus sampling (CVS) are commonly performed, these
procedures are not without risk.
1–3 The best known
complications due to amniocentesis and CVS are preg-
nancy loss and limb defects.
1–3 A lesser known but also
frequently occurring complication after CVS is the
development of hemangioma in the newborn.
4–7 This
is in line with the hypothesis that hemangiomas
are formed due to the embolization of placental tropho-
blast cells. If this is indeed the case, it can
be expected that transabdominal chorionic villus
sampling (TA-CVS) in which the sample size is
smaller, carries a smaller risk on the formation of
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procedures and the formation of hemangioma did,
however, not differentiate between transcervical and
transabdominal CVS.
4–7
In a previous study we compared the effect of 250
consecutive amniocentesis procedures to 250 consecu-
tive transcervical CVS (TC-CVS) procedures on the
prevalence of hemangiomas. We found that children in
the TC-CVS group had a signiﬁcantly increased preva-
lence of hemangiomas compared to the amniocentesis
group (OR 3.6, 95% CI 2.0 – 6.5, P < 0.001).
8 The aim of
thepresentstudywastoinvestigateifTA-CVS,inwhich
sample size and thus placental damage is smaller com-
pared to TC-CVS, also resulted in an increased preva-
lence of hemangiomas again compared to a group of
subjects in which amniocentesis was performed.
Material and Methods
Study design
The study contains two cohorts of patients that were
selected from 200 consecutive assessable TA-CVS
and 200 consecutive assessable amniocentesis proce-
dures between April and September 2001 in the
Radboud University Medical Center in Nijmegen, the
Netherlands.
Exclusion criteria were twin pregnancy, elective
abortion, stillbirth, perinatal infant mortality, inability
to locate the family or inability to ascertain from the
medical ﬁles that the child was alive and doing well
after birth.
Questionnaires were sent to the parents asking if
there was any skin mark on the child, including vascu-
lar or pigmented lesions or any other skin lesion. When
a skin lesion of any kind (stork bite, birthmark, heman-
gioma or pigmented lesion) was mentioned, the
parents and the child were asked to visit the clinic in
the autumn of 2002 for a physical examination by the
authors (CGB and SMS). The parents were encouraged
to bring multiple photographs for afﬁrmative docu-
mentation. Based on this information an estimate was
made about the growth pattern of the hemangiomas.
When the parents were unable or unwilling to visit
our research clinic, a medical history was obtained by
telephone call and they were asked to send pictures.
Their general physician was instructed and asked to
examine the child. Directly after the examination the
general physician was contacted to report the outcome.
Iftheparentswerealsounwillingorunabletovisittheir
familyphysician,thechildwasexcludedfromthestudy.
Technical details of procedures
TA-CVS biopsy was performed 10–12 weeks after con-
ception by insertion of a 0.9-mm needle transabdomi-
nally in the placenta as a guidance to obtain a villus
sample. Amniocentesis was performed 15–17 weeks
after conception with a 20-gauge needle. All proce-
dures were performed under ultrasound guidance.
Statistics
For statistical analysis commercially available software
(SPSS 17.0, IBM, New York, NY, USA) was used. Values
are represented as mean  standard deviation. For
comparison of categorical data, c
2, or when appropriate
Fisher’s exact tests, were used. For comparison of con-
tinuous variables, unpaired t-tests (normal distribu-
tion) or Mann-Whitney U-tests (skewed distribution)
were used. The distribution of variables (normally
versus skewed) was analysed using one-sample
Kolmogorov-Smirnov test. Statistical values are only
mentioned in the text when statistical signiﬁcance was
reached. Signiﬁcance was set at P < 0.05.
Results
Forty-two TA-CVS procedures and 27 amniocentesis
procedures were excluded on the predeﬁned criteria.
Consequently, the two study cohorts consisted of 158
CVS procedures and 173 amniocentesis procedures. In
the TA-CVS group, 118 questionnaires (75%), and in
the amniocentesis group 134 questionnaires (77%)
were returned, and formed the basis for further analy-
sis. Baseline characteristics of the newborn and techni-
cal details on prenatal diagnostic procedures within
both groups are summarized in Table 1 and did not
differ between the TA-CVS and amniocentesis groups,
except for gestational age at the time of procedure.
Based on the results of the questionnaire (i.e. mention-
ing of any skin lesion), 24 children in the TA-CVS
group and 42 children in the amniocentesis group
qualiﬁed for a physical examination. In the TA-CVS
group 11 children were examined by the authors and
nine by the general physician. For the amniocentesis
group these numbers were 21 and 13, respectively.
Indication for diagnostic procedure
The indications for amniocentesis and TA-CVS did
not differ from those found in the literature.
9 The
most frequent indication in the amniocentesis group
was maternal age: 84% (112 cases). Other indications
for performing amniocentesis were chromosomal
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abnormality (n = 9), lowered alpha-fetoprotein (n = 1)
and parental request (n = 1). In the TA-CVS group
the most frequent indication was maternal age as
well: 87% (103 cases). Other indications were chro-
mosomal disorder in a sibling or parent (n = 12),
nuchal translucency (n = 2) and parental request
(n = 1).
Parental background and sex distribution
The ethnic background for the amniocentesis group
was similar in both groups. Parents were derived from
the Netherlands, other European countries, North
America, SouthAmerica,Africa, South-EastAsia or the
Middle East. All hemangiomas were found in children
with white parents.
The male-to-female ratio in the TA-CVS study group
was 60:58 and 72:62 in the amniocentesis group.
Details of prenatal diagnostic procedure
With amniocentesis, the mean amount of ﬂuid
retrieved was 21 mL (mean 21, SD 1.4, range 14–28).
In 124 cases only one needle insertion was needed
and, in 10 cases two insertions were necessary. In the
TA-CVS group the mean sample size was 23 mg
(mean 23, SD 10.0, range 1–45). In 108 cases one
needle insertion was needed and in 10 cases two
needle insertions were done. There was no signiﬁcant
correlation between the number of insertions and the
prevalence of hemangiomas (Table 1).
Congenital abnormalities
The incidence of congenital abnormalities was similar
in both groups: 9.0% in the amniocentesis group (con-
genital heart disease, Down syndrome, Fallot’s tetral-
ogy, esophagus atresia, syndactily, polydactily, kidney
dysplasia, cleft lip, hydrocephalus, adrenocongenital
disease and difference in length of the legs), and 7.6%
in the TA-CVS group (macrosomy, syndactily, pulmo-
nary stenosis, CDG syndrome, hydrocele and nail
deformities).
Prevalence of hemangiomas
In the TA-CVS group 11 children had one or more
hemangiomas. In the amniocentesis group six children
had one or more hemangiomas. There was no statistical
difference between the two groups (P = 0134).
Characteristics of hemangiomas
There were not signiﬁcantly more patients with mul-
tiple hemangiomas in the TA-CVS group. There were
no differences for anatomical distribution, maximum
size of the hemangiomas and the growth hallmarks:
infant age at maximum size of the hemangiomas and at
the start of the involution. The male-to-female ratio for
the children with a hemangioma was 4:7 in the TA-CVS
group and 4:2 in the amniocentesis group. The gender
distribution was not statistically signiﬁcantly different
for the children with a hemangioma in both groups.
There were no complications of the hemangiomas
(Table 2).
Discussion
Reports on the prevalence of hemangiomas vary; gen-
erally the prevalence of hemangiomas in Caucasian
children is reported at 10%.
10 In our population we
found a prevalence of 9% in the TA-CVS group versus
4% in the amniocentesis group. The prevalence of
hemangiomas in the amniocentesis group is lower than
one would expect from the literature. We could not
ﬁnd a good explanation for this.
To date there is no universally accepted theory that
explains the pathogenesis and the pathophysiology of
Table 1 Baseline characteristics of the transabdominal chorionic villus sampling (TA-CVS) and amniocentesis (AC) group
TA-CVS group AC group P-value
(n = 118) (n = 134)
Newborn
Gestational age at birth (days) 278  13 276  13 P = 0.090
Birth weight (g) 3495  486 3416  647 P = 0.284
Congenital abnormalities 7.6% (9) 9.0% (12) P = 0.703
Male-to-female ratio 1.03:1.00 (60:58) 1.16:1.00 (72:62) P = 0.647
Procedure
Gestational age at time of procedure (days) 82  6 116  26 P < 0.001
Indication for procedure is maternal age 103 (87%) 112 (84%) P = 0.407
Multiple needle insertions 10 (8.5%) 10 (7.5%) P = 0.834
Maternal age at time of procedure 36.8  3.3 years 36.8  3.1 years P = 0.826
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common expression of several pathophysiological
mechanisms. One of these mechanisms is the embo-
lization of placental trophoblast cells.
11,12 The embo-
lized cells lie dormant during intrauterine life. After
birth these cells proliferate and form a hemangioma. It
has been shown that a TC-CVS procedure leads to
immediate hemorrhagic lesions in 30% of the cases.
13 It
seems, therefore, reasonable to expect a higher preva-
lence of hemangiomas after a TC-CVS procedure.
One study showed that in a combined group of TC-
and TA-CVS procedures there is an increased risk of
hemangiomas.
4 Unfortunately, these hemangiomas
were clinically unconﬁrmed and no differentiation was
made between TC- and TA-CVS. In a previous study
we have shown that TC-CVS can lead to a highly
increased incidence of clinically conﬁrmed hemangio-
mas compared to amniocentesis: 27% versus 9%
respectively.
8 In that study the CVS biopsies were per-
formed at 10–12 weeks’ amenorrhea under ultrasound
guidance. In most cases one needle insertion was suf-
ﬁcient and a mean sample size of 90 mg (mean 90, SD
30, range 40–200) was taken for analysis. In this study
no increased risk for hemangiomas was observed after
transabdominal CVS. In the current study the CVS
biopsy was also performed 10–12 weeks after concep-
tion under ultrasound guidance. Also, in most cases
one needle insertion was sufﬁcient, but the mean size
of the tissue sample was considerably smaller, 23 mg
(mean 23, SD 10.0, range 1–45) respectively. If the
TC-CVS group of our previous study and TA-CVS of
the current study are compared on the prevalence of
hemangiomas, the prevalence of hemangiomas in the
TC-CVS is group is signiﬁcantly higher, 27% versus 9%
respectively (P < 0.001).
Future research will be needed to explain the exact
correlation between CVS and hemangiomas. Never-
theless, the current results seem to indicate that the size
of the biopsy is a crucial factor. This is supported by the
fact that the size of the biopsy is directly correlated to
the amount of placental trauma and trophoblast
embolization.
Although this study adds to the discussion about the
pathogenesis and pathophysiology of hemangiomas, it
has several ﬂaws. First of all because of its retrospective
character, the prevalence is not exact. For a more accu-
rate estimation of the incidence of the hemangioma in
the newborn, a prospective cohort is needed. Second,
there is a difference in the prevalence of hemangiomas
between the two groups of 5%, although we did not
ﬁnd this difference to be statistically different, a larger
research study population might have proven a statis-
tical signiﬁcant difference. A post-hoc power analysis
shows that over 1100 patients are needed to test the
hypothesis with a signiﬁcance level of 5% and a power
of 80%. Further, approximately one-quarter of the
questionnaires were not returned.Although we tried to
achieve a higher response rate by contacting parents
who did not return the questionnaire, we did not
achieve higher response rates. In some cases it was not
Table 2 Hemangioma characteristics of the transabdominal chorionic villus sampling (TA-CVS) and amniocentesis (AC)
group
TA-CVS group AC group P-value
Prevalence of hemangiomas 9.3% 4.5% P = 0.134
No. children with hemangiomas 11 6
Total no. hemangiomas 14 14
Male-to-female ratio 4:7 4:2 P = 0.232
Children with visible hemangioma at birth 1 0
Complications of hemangiomas 0 0





Max area of haemangioma 2.6  3.2 cm
2 3.6  3.0 cm
2 P = 0.530
Age at maximum size 4  2 months 4  4 months P = 0.858
Age at start of involution 8  2 months 7  3 months P = 0.406
Anatomical location of hemangioma P = 0.145
Head and neck area 2/14 3/14
Extremities 2/14 6/14
Trunk, including genitalia 10/14 5/14
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not up-to-date anymore, and several parents were
unwilling to ﬁll in the form for different reasons.
Finally, only hemangiomas that were externally visible
are included. Internally located hemangiomas will be
missed with this study design. Therefore the preva-
lence is potentially underestimated. It is, however, dif-
ﬁcult to include internally located hemangiomas in a
study design without considerably increasing the
burden on patients.
These results suggest that TA-CVS does not cause an
increase in the prevalence of hemangiomas. A larger
series, however, is necessary to conﬁrm this.
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